YM BioSciences reports operational and financial results for the first quarter of fiscal 2012
MISSISSAUGA, ON, Nov. 11, 2011 /CNW/ - YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer-related products, today reported operational and financial results for its first quarter of fiscal 2012, ended September 30, 2011.
Biogen Idec Inc. today announced it will report first quarter 2012 financial results on Tuesday, May 1, 2012, before the financial markets open.